Duloxetine Capsule, Delayed Release
Product Images NDC 71335-1672

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 71335-1672). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Duloxetine Fig 5

A line graph showing percentage of patients improved versus percent improvement in pain from baseline. It compares Duloxetine HCL 60 mg taken twice daily, Duloxetine HCL 60 mg taken once daily, and placebo, with the percentage of patients improved generally higher for the twice daily dose.*

FDA Label Image

Duloxetine Fig 6

A line graph showing the percentage of patients improved versus percent improvement in pain from baseline. The graph compares four groups: Duloxetine HCL 120mg once daily, Duloxetine HCL 60mg once daily, Duloxetine HCL 20mg once daily, and placebo. Each group is represented by a distinct line and marker type, illustrating patient response trends at varying levels of pain improvement.*

FDA Label Image

Duloxetine-fig3 (Duloxetine Fig3)

A line graph depicting the percentage of patients improved against percent improvement in pain from baseline. The graph compares Duloxetine HCl at doses of 60 mg twice daily, 60 mg once daily, 20 mg once daily, and placebo, showing patient improvement across different levels of pain reduction.*

FDA Label Image

Duloxetine-fig4 (Duloxetine Fig4)

A line graph depicting the percentage of patients improved versus percent improvement in pain from baseline. Three lines compare Duloxetine HCl 60 mg twice daily, Duloxetine HCl 60 mg once daily, and placebo groups.*

FDA Label Image

Duloxetine-fig7 (Duloxetine Fig7)

A line graph comparing the percentage of patients improved against percent improvement in pain from baseline (BOCF) for Placebo and Duloxetine 60/120 mg once daily. The graph plots two curves showing patient response over a range of pain improvement percentages, with Duloxetine generally showing higher percentage improvements than placebo.*

FDA Label Image

Duloxetine-fig8 (Duloxetine Fig8)

A line graph showing the percentage of patients improved versus percent improvement in pain from baseline (BOCF). It compares two groups: placebo and duloxetine 60 mg once daily, depicting duloxetine generally showing higher improvement percentages across increasing pain improvement levels.*

FDA Label Image

Duloxetine-figure1 (Duloxetine Figure1)

A Kaplan-Meier curve chart comparing the proportion of patients with relapse over time from randomization in days. The chart includes two treatment groups: Placebo and Duloxetine, showing the difference in relapse rates over approximately 200 days.*

FDA Label Image

Duloxetine-figure2 (Duloxetine Figure2)

A line graph showing the proportion of patients with relapse over time in days from randomization, comparing placebo and duloxetine treatments. The x-axis represents time from randomization to relapse in days, and the y-axis represents the proportion of patients with relapse, ranging from 0 to 1. Duloxetine shows a lower relapse proportion over time compared to placebo.*

FDA Label Image

Duloxetine-structure (Duloxetine Structure)

Chemical structure of duloxetine showing its molecular framework including a naphthalene ring, a thiophene ring, and an amine group as part of its skeletal formula.*

FDA Label Image

Label Image (Lbl713351672)

Label for Duloxetine DR 30 mg delayed release capsules, packaged by Bryant Ranch Prepack in Burbank, CA. The label indicates the product is comparable to Cymbalta 30 mg capsules by Alkem Laboratories Ltd. It shows the capsule described as white and blue, includes storage instructions at 20°-25°C, and contains the NDC number 71335-1672-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.